Vascular Neurology Considerations for Anti-Amyloid Immunotherapy
You are currently not logged in to PHD
To view this content, please login to your account, or within the login, click 'Create an Account' for guest access. To access AHA's full array of membership benefits, join or renew today!
Please note: AHA does not associate with, nor endorse YouTube recommendations.
Authors Mark Fisher, MD and Steve Greenberg, MD announce the publication of the science advisory in the journal STROKE and discuss predictors of ARIA, the use of antithrombotic and thrombolytic medications in patients receiving anti-amyloid therapy, and suggested treatment approaches.
Recommended Videos
Assessment of Insomnia in an Office Visit
Medications to Treat Insomnia
Diagnosing Medication Non-Adherence in Hypertension Treatment
Therapeutic Inertia and Medication Non-Adherence in Hypertension Treatment
What to do if an Incidental Cardiovascular Variant is Identified
Loading...
Save Video
Please note: AHA does not associate with, nor endorse YouTube recommendations.
Video is not available. Please check the URL.